Identifying and Targeting ROS1 Gene Fusions in Non―Small Cell Lung Cancer von DAVIES, Kurtis D, LE, Anh T, ALLOISIO, Marco, SANTORO, Armando, ROSS CAMIDGE, D, VARELLA-GARCIA, Marileila, DOEBELE, Robert C, THEODORO, Mariana F, SKOKAN, Margaret C, AISNER, Dara L, BERGE, Eamon M, TERRACCIANO, Luigi M, CAPPUZZO, Federico, INCARBONE, Matteo, RONCALLI, Massimo

Volltext

Targeted Therapies in Non-Small Cell Lung Cancer: Emerging Oncogene Targets Following the Success of Epidermal Growth Factor Receptor von Berge, Eamon M, Doebele, Robert C

Volltext

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer von Vaishnavi, Aria, Capelletti, Marzia, Le, Anh T, Kako, Severine, Butaney, Mohit, Ercan, Dalia, Mahale, Sakshi, Davies, Kurtis D, Aisner, Dara L, Pilling, Amanda B, Berge, Eamon M, Kim, Jhingook, Sasaki, Hidefumi, Park, Seung-il, Kryukov, Gregory, Garraway, Levi A, Hammerman, Peter S, Haas, Julia, Andrews, Steven W, Lipson, Doron, Stephens, Philip J, Miller, Vince A, Varella-Garcia, Marileila, Jänne, Pasi A, Doebele, Robert C

Volltext

A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Tr... von McCoach, Caroline E., Berge, Eamon M., Lu, Xian, Barón, Anna E., Camidge, D. Ross

Volltext

A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer von Camidge, D. Ross, Berge, Eamon M., Doebele, Robert C., Ballas, Marc S., Jahan, Thierry, Haigentz, Missak, Hoffman, David, Spicer, James, West, Howard, Lee, Pablo, Yang, Ling, Joshi, Adarsh, Gao, Ling, Yurasov, Sergey, Mita, Alain

Volltext

Re-examination of Maintenance Therapy in Non-Small Cell Lung Cancer with the Advent of New Anti-cancer Agents von Berge, Eamon M., Doebele, Robert C.

Volltext

Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR von Berge, Eamon M., Aisner, Dara L., Doebele, Robert C.

Volltext

Clinical Benefit From Pemetrexed Before and After Crizotinib Exposure and From Crizotinib Before and After Pemetrexed Exposure in Patients With Anaplastic Lymphoma Kinase-Positive... von Berge, Eamon M, Lu, Xian, Maxson, Delee, Barón, Anna E, Gadgeel, Shirish M, Solomon, Benjamin J, Doebele, Robert C, Varella-Garcia, Maria, Camidge, D. Ross

Volltext

EGFR Exon 19 Deletion Mutations and Systemic/Central Nervous System Miliary Metastasis: Clinical Correlations and Response to Therapy von Poonia, Seerat, Berge, Eamon M, Aisner, Dara L, Damek, Denise, Doebele, Robert C

Volltext

Targeted Therapies in NSCLC: Emerging oncogene targets following the success of EGFR von Berge, Eamon M, Doebele, Robert C

Volltext

RET rearrangements detected by FISH in “pan-negative” lung adenocarcinoma von Varella-Garcia, Marileila, Xu, Liang Guo, Mahale, Sakshi, Berge, Eamon M, Bennati, Chiara, Le, Anh T., Aisner, Dara, Crinò, Lucio, Bunn, Paul A., Camidge, D. Ross, Doebele, Robert Charles

Volltext

Analysis of resistance mechanisms to ALK kinase inhibitors in ALK+ NSCLC patients von Doebele, Robert Charles, Aisner, Dara L, Le, Anh T, Berge, Eamon M, Pilling, Amanda B., Kutateladze, Tatiana G., Weickhardt, Andrew James, Franklin, Wilbur A., Varella-Garcia, Marileila, Camidge, D. Ross

Volltext

Abstract LB-449: KRAS mutation and amplification status predicts sensitivity to antifolate therapies in non-small-cell lung cancer von Moran, Diarmuid M., Trusk, Patricia, Shell, Scott A., Camidge, D. Ross, Doebele, Robert C., Berge, Eamon, Vincent, Mark, Bacus, Sarah

Volltext